Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Apr 4, 2017 06:15PM Unilife Corp. (UNIS) Sinks After Warning About Dire Financial Condition, Executing WARN Notice
Mar 28, 2017 06:49PM Form 4 Adaptimmune Therapeutics For: Mar 27 Filed by: ORBIMED ADVISORS LLC
Mar 27, 2017 04:25PM Form SC 13D Aerpio Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Mar 21, 2017 05:07PM Form SC 13D/A ViewRay, Inc. Filed by: ORBIMED ADVISORS LLC
Mar 7, 2017 06:48PM Form 4 GLAUKOS Corp For: Mar 03 Filed by: ORBIMED ADVISORS LLC
Mar 7, 2017 04:01PM Lion Biotechnologies Reports Fourth Quarter and Full-Year 2016 Financial Results and Provides Corporate Update
Mar 6, 2017 04:55PM Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Feb 22, 2017 08:00AM PMV Pharma Secures $74 Million in Series B Financing for Cancer Drugs Targeting p53
Feb 21, 2017 05:58PM Form 4 Aeglea BioTherapeutics, For: Feb 16 Filed by: ORBIMED ADVISORS LLC
Feb 14, 2017 04:34PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 14, 2017 11:52AM venBio Takes Steps to Protect Immunomedics (IMMU) Stockholders Following Its Partnership with Seattle Genetics (SGEN)
Feb 14, 2017 11:50AM venBio Takes Steps to Protect Rights of Immunomedics Stockholders
Feb 13, 2017 02:22PM Form SC 13G/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:20PM Form SC 13G/A XENOPORT INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:18PM Form SC 13G/A Sientra, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:17PM Form SC 13G/A SYNERGY PHARMACEUTICALS, Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:16PM Form SC 13G NEWLINK GENETICS CORP Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:15PM Form SC 13G Lion Biotechnologies, Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:14PM Form SC 13G INOTEK PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:12PM Form SC 13G/A IMMUNOMEDICS INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:11PM Form SC 13G/A IMMUNOGEN INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:10PM Form SC 13G/A GLAUKOS Corp Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:09PM Form SC 13G/A FLUIDIGM CORP Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 02:07PM Form SC 13G Cellectis S.A. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:57PM Form SC 13G/A Wright Medical Group Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:55PM Form SC 13G/A ProQR Therapeutics N.V. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:53PM Form SC 13G/A PUMA BIOTECHNOLOGY, INC. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:51PM Form SC 13G/A MAGELLAN HEALTH INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:51PM Form SC 13G/A Ophthotech Corp. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:49PM Form SC 13G/A IRONWOOD PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:47PM Form SC 13G/A Insys Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:47PM Form SC 13G/A IMPAX LABORATORIES INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:44PM Form SC 13G/A INSMED Inc Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:42PM Form SC 13G/A INFINITY PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:41PM Form SC 13G/A eHealth, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:39PM Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:38PM Form SC 13G/A Sierra Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:36PM Form SC 13G/A CONNECTURE INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:35PM Form SC 13G/A ARRAY BIOPHARMA INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:35PM Form SC 13G/A CERUS CORP Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:32PM Form SC 13G/A AFFYMETRIX INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:30PM Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: ORBIMED ADVISORS LLC
Feb 10, 2017 04:14PM venBio Comments on Immunomedics Partnership Announcement
Feb 7, 2017 04:56PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 6, 2017 06:58AM ISS Endorses Full Slate of venBio Nominees at Immunomedics
Feb 3, 2017 01:25PM Form SC 13G ObsEva SA Filed by: ORBIMED ADVISORS LLC
Feb 2, 2017 02:25PM OrbiMed Comments on Immunomedics Proxy Contest
Jan 27, 2017 01:10PM Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Jan 20, 2017 04:25PM Form 4 ViewRay, Inc. For: Jan 18 Filed by: ORBIMED ADVISORS LLC
Jan 20, 2017 04:20PM Form SC 13D/A ViewRay, Inc. Filed by: ORBIMED ADVISORS LLC

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed